{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:53Z","timestamp":1786997933352,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.vaccine.2009.08.018","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T06:13:53Z","timestamp":1251267233000},"page":"6179-6185","source":"Crossref","is-referenced-by-count":36,"title":["Fusion protein Ag85B-MPT64190\u2013198-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Yu","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejiao","family":"Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Qie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.08.018_bib1","series-title":"Global tuberculosis control\u2013surveillance, planning, financing, WHO report, 1","author":"Anonymous","year":"2006"},{"key":"10.1016\/j.vaccine.2009.08.018_bib2","series-title":"Tuberculosis-Fact Sheet104","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.vaccine.2009.08.018_bib3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrmicro1050","volume":"2","author":"Onyebujoh","year":"2004","journal-title":"Tuberculosis Nature Reviews Microbiology"},{"issue":"Suppl. (3)","key":"10.1016\/j.vaccine.2009.08.018_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with Bacillus Calmette Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vaccine.2009.08.018_bib5","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2007.01.112","article-title":"Current status of TB vaccines","volume":"25","author":"Gupta","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.018_bib6","unstructured":"Palomino JC, Le\u00e3o SC, Ritacco V, Tuberculosis 2007 From basic science to patient care. In: Carlos M, Fabiana B, Brigitte G, editors, New vaccines against tuberculosis, www.TuberculosisTextbook.com, 341\u201360."},{"key":"10.1016\/j.vaccine.2009.08.018_bib7","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2005.07.037","article-title":"Frequency of IFN-\u03b3 producing cells correlates with adjuvant enhancement of bacille Calmette\u2013Gu\u00e9rin induced protection against Mycobacterium bovis","volume":"23","author":"Logan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.018_bib8","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.vaccine.2006.03.072","article-title":"Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31","volume":"24","author":"Agger","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.018_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1389201033377931","article-title":"Selecting the components for a safe and efficient tuberculosis subunit vaccine-recent progress and post-genomic insights","volume":"4","author":"Okkels","year":"2003","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.vaccine.2009.08.018_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2006.10.010","article-title":"Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity","volume":"122","author":"Sable1SB","year":"2007","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.vaccine.2009.08.018_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.vaccine.2009.08.018_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2567.2007.02597.x","article-title":"Increased levels of interferon-\u03b3 primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection","volume":"121","author":"Fonseca","year":"2007","journal-title":"Immunology"},{"issue":"Suppl. (3)","key":"10.1016\/j.vaccine.2009.08.018_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1843.2008.01350.x","article-title":"Immunopathogenesis of tuberculosis: implications for vaccine development","volume":"13","author":"Zhang","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.vaccine.2009.08.018_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejpb.2006.11.028","article-title":"Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis","volume":"66","author":"Zhu","year":"2007","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.vaccine.2009.08.018_bib15","first-page":"481","article-title":"Effect of BCG-PSN on TH1 aim TH2 cytokine responses of peripheral blood mononuclear cells from atopic asthmatics","volume":"25","author":"Lai","year":"2005","journal-title":"China Journal Microbiology and Immunology"},{"key":"10.1016\/j.vaccine.2009.08.018_bib16","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1128\/IAI.67.11.5967-5971.1999","article-title":"T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts","volume":"67","author":"Demissie","year":"1999","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2009.08.018_bib17","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.vaccine.2005.01.062","article-title":"Current progress in tuberculosis vaccine development","volume":"23","author":"Orme","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.018_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pep.2007.11.016","article-title":"Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model","volume":"59","author":"Bai","year":"2008","journal-title":"Protein Expression and Purification"},{"key":"10.1016\/j.vaccine.2009.08.018_bib19","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs","volume":"11","author":"Brandt","year":"2004","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2009.08.018_bib20","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette\u2013Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"The Journal of Immunology"},{"issue":"179","key":"10.1016\/j.vaccine.2009.08.018_bib21","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.200809-1486OC","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals","volume":"15","author":"Sander","year":"2009","journal-title":"American Journal of Respiration and Critical Care Medicine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09011943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09011943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T15:00:09Z","timestamp":1590073209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09011943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":21,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0264410X09011943"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}